A recent study has found that cancer cells can steal energy from immune cells to fuel their own growth, adding another layer to the battle against cancer and opening the door for potential future treatments. Concurrently, advancements are being made in the fight against this disease. The recent expansion of the FDA's approval of pembrolizumab, a drug used against stomach and esophageal junction cancer, showcases significant progress. This change heralds a new era of cancer treatment. Additionally, the drug selpercatinib shows promise in improving survival rates for lung and thyroid cancer patients, adding optimism to the often grim outlook associated with these illnesses.
Full article here: https://lawsuithelpdesk.com/1-cancer-cells-terrifying-tactics-stealing-energy-from-immune-cells-2-revolution-in-cancer-care-fdas-new-stance-on-pembrolizumab-3-hope-rises-selpercatinibs-potential-for-lung-and-thy/